Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial
Rick Admiraal, Stefan Nierkens, Marc Bierings, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 2, pp. e111-e120
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection
Kangping Yang, Yihan Zhang, Jiatong Ding, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Personalized hematopoietic stem cell transplantation for inborn errors of immunity
Mary Slatter, Su Han Lum
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Bodyweight and Absolute Lymphocyte Count-Based Dosing of Rabbit Anti-Thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation
Daniel Drozdov, Jessica Kandil, Susan E. Long, et al.
Transplantation and Cellular Therapy (2025)
Open Access
A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation
Shiyuan Zhou, Chao Ma, Danping Zhou, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 1, pp. 103501-103501
Open Access
Reduced cytomegalovirus reactivation and viremia without increased GVHD after URD-PBSCT: A prospective study using targeted ATG dosing
Sheng Chen, Lu Wang, Songhua Luan, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias
Abdullah Karakuş, Tayfur Toptaş, Mehmet Sinan Dal, et al.
Bone Marrow Transplantation (2025)
Open Access
Highlights into historical and current immune interventions for cancer
Kathryn Cole, Zaid Al‐Kadhimi, James E. Talmadge
International Immunopharmacology (2023) Vol. 117, pp. 109882-109882
Open Access | Times Cited: 9
Individualized rabbit anti‐thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high‐risk hematologic malignancy: Exposure–response analysis and population pharmacokinetics simulations
Masahiro Teramoto, Takuto Takahashi, Kana Matsumoto, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 3, pp. 387-395
Closed Access | Times Cited: 3
Recent advances in graft-versus-host disease
Aisling M. Flinn, Andrew R. Gennery
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 8
Targeted dosing of anti‐thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single‐arm, phase 2 trial
Haitao Wang, Nan Wang, Lili Wang, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 11, pp. 1732-1741
Closed Access | Times Cited: 8
The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol
Ambreen Pandrowala, Sanna Khan, Darshan Kataria, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Donor‐specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report
Binni Kunvarjee, Gloria Contreras Yametti, Amanda G. Blouin, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1540-1544
Open Access | Times Cited: 2
Individualized dose of anti-thymocyte globulin based on weight and pre-transplantation lymphocyte counts in pediatric patients: a single center experience
Francisco Barriga, Angélica Wietstruck, Clara Schulze, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 4, pp. 473-478
Open Access | Times Cited: 2
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
Ann‐Christin Pecher, Reinhild Klein, I. Koetter, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Effect of Rabbit ATG PK on Outcomes after TCR-αβ/CD19-depleted Pediatric Haploidentical HCT for Hematologic Malignancy
Christopher C. Dvorak, Janel Long-Boyle, Lucia Holbrook-Brown, et al.
Blood Advances (2024) Vol. 8, Iss. 23, pp. 6003-6014
Open Access | Times Cited: 2
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
Vera Domingos, Kateřina Nezvalová‐Henriksen, Adrin Dadkhah, et al.
Bone Marrow Transplantation (2024)
Closed Access | Times Cited: 2
Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
M. Y. Eileen C. van der Stoep, Lisa V. E. Oostenbrink, Robbert G. M. Bredius, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
Linde Dekker, Evy Sanders, Caroline A. Lindemans, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Graft-versus-host disease: teaching old drugs new tricks at less cost
Shatha Farhan, Shernan G. Holtan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival
Caridad Martinez, Paibel Aguayo‐Hiraldo, Natalia S. Chaimowitz, et al.
Blood Advances (2022) Vol. 7, Iss. 9, pp. 1823-1830
Open Access | Times Cited: 8
Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy
Takuto Takahashi, Masahiro Teramoto, Kana Matsumoto, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 8, pp. 1081-1091
Closed Access | Times Cited: 4
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
Madhavi Lakkaraja, Audrey Mauguen, Farid Boulad, et al.
Cytotherapy (2024) Vol. 26, Iss. 4, pp. 351-359
Closed Access | Times Cited: 1
High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant
Rick Admiraal, A. Birgitta Versluijs, Alwin D. R. Huitema, et al.
Cytotherapy (2024) Vol. 26, Iss. 6, pp. 599-605
Open Access | Times Cited: 1
Model-Based Antithymocyte Globulin in αβhaplo-Hematopoietic Stem Cell Transplantation Facilitates Engraftment, Expedites T Cell Recovery, and Mitigates the Risk of Acute Graft-versus-Host Disease
Giulia Barbarito, Lyndsie Hiroshima, Linda Oppizzi, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 8, pp. 810.e1-810.e16
Closed Access | Times Cited: 1
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies
Yanlu Du, Ying Zhang, Xiaowei Xu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 9, pp. 3765-3774
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top